Schedule 13D ownership disclosure
PERNIX THERAPEUTICS HOLDINGS, INC.
Security class unavailable · CUSIP: 71426V108
Event date: 2016-04-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 182,295
- Percent of class
- 0.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-16-114730
- Form type
- SC 13D
- Filer
- Cetus Capital II, LLC
- CIK
- CIK 1561987
- Filed
- Apr 27, 2016
- Reporting period
- Apr 25, 2016
- Description
- Schedule 13D beneficial ownership